Yancopoulos G D, Nolan G P, Pollock R, Prockop S, Li S C, Herzenberg L A, Alt F W
Howard Hughes Medical Institute, New York, New York.
Mol Cell Biol. 1990 Apr;10(4):1697-704. doi: 10.1128/mcb.10.4.1697-1704.1990.
We describe two retroviral vector-based recombination substrate systems designed to assay for lymphoid VDJ recombinase activity in cultured cells. Both substrates incorporate a constitutive dominant marker gene (the simian virus promoter-driven neo gene) to allow selection of cells that stably integrate the substrate. Both substrates also include a second marker gene that becomes transcriptionally active only when inverted by a site-specific recombination event between flanking immunoglobulin variable-region gene segments. The first vector, similar in structure to previous retrovirus-based recombination substrates, utilizes the bacterial guanine-xanthine phosphoribosyltransferase gene (gpt) as its activatable marker; detection of inversion (VDJ recombinase activity) involves drug selection and Southern blotting analyses. We have used this vector to make a more extensive and quantitative survey of VDJ recombinase activity in B-lineage cell lines than has previously been performed with stable substrates, and we have compared our results with those of other studies that use transient recombination substrates. In the second vector, the activatable gene is the bacterial beta-galactosidase gene (lacZ). Detection for inversional activation of this gene is achieved by a fluorogenic assay, termed FACS-Gal, that detects beta-galactosidase activity in viable cells. The latter assay has the unique advantage of rapidly detecting cells that undergo recombination and also allows viable sorting of cells on the basis of the presence or absence of VDJ recombinase activity. We have used the lacZ vector to rapidly quantitate VDJ recombinase activity in B-lineage cell lines and compared the results with those obtained with the gpt vector. We have also used the lacZ vector to isolate variant pre-B-cell lines with low and high levels of VDJ recombinase activity.
我们描述了两种基于逆转录病毒载体的重组底物系统,旨在检测培养细胞中的淋巴细胞VDJ重组酶活性。两种底物都包含一个组成型显性标记基因(猿猴病毒启动子驱动的neo基因),以允许选择稳定整合底物的细胞。两种底物还包括第二个标记基因,该基因只有在侧翼免疫球蛋白可变区基因片段之间发生位点特异性重组事件而被倒置时才会转录激活。第一种载体的结构与以前基于逆转录病毒的重组底物相似,利用细菌鸟嘌呤-黄嘌呤磷酸核糖转移酶基因(gpt)作为其可激活标记;倒置(VDJ重组酶活性)的检测涉及药物选择和Southern印迹分析。我们使用这种载体对B系细胞系中的VDJ重组酶活性进行了比以前使用稳定底物时更广泛和定量的调查,并将我们的结果与其他使用瞬时重组底物的研究结果进行了比较。在第二种载体中,可激活基因是细菌β-半乳糖苷酶基因(lacZ)。该基因的倒置激活检测通过一种荧光测定法实现,称为FACS-Gal,它可检测活细胞中的β-半乳糖苷酶活性。后一种测定法具有快速检测发生重组的细胞的独特优势,并且还允许根据VDJ重组酶活性的有无对细胞进行活细胞分选。我们使用lacZ载体快速定量B系细胞系中的VDJ重组酶活性,并将结果与用gpt载体获得的结果进行比较。我们还使用lacZ载体分离了具有低水平和高水平VDJ重组酶活性的前B细胞系变体。